122 related articles for article (PubMed ID: 25540359)
1. Reduction of HIV-1 infectivity through endoplasmic reticulum-associated degradation-mediated Env depletion.
Casini A; Olivieri M; Vecchi L; Burrone OR; Cereseto A
J Virol; 2015 Mar; 89(5):2966-71. PubMed ID: 25540359
[TBL] [Abstract][Full Text] [Related]
2. Human Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner.
Bohl CR; Abrahamyan LG; Wood C
PLoS One; 2013; 8(7):e69359. PubMed ID: 23861967
[TBL] [Abstract][Full Text] [Related]
3. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
4. Intracellular degradation of the HIV-1 envelope glycoprotein. Evidence for, and some characteristics of, an endoplasmic reticulum degradation pathway.
Courageot J; Fenouillet E; Bastiani P; Miquelis R
Eur J Biochem; 1999 Mar; 260(2):482-9. PubMed ID: 10095785
[TBL] [Abstract][Full Text] [Related]
5. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding.
Li Y; Luo L; Thomas DY; Kang CY
Virology; 2000 Jul; 272(2):417-28. PubMed ID: 10873786
[TBL] [Abstract][Full Text] [Related]
6. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Vpr increases Env expression by preventing Env from endoplasmic reticulum-associated protein degradation (ERAD).
Zhang X; Zhou T; Frabutt DA; Zheng YH
Virology; 2016 Sep; 496():194-202. PubMed ID: 27343732
[TBL] [Abstract][Full Text] [Related]
8. The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathway.
Zhou T; Dang Y; Zheng YH
J Virol; 2014 Mar; 88(6):3474-84. PubMed ID: 24403586
[TBL] [Abstract][Full Text] [Related]
9. ERManI (Endoplasmic Reticulum Class I α-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway.
Zhou T; Frabutt DA; Moremen KW; Zheng YH
J Biol Chem; 2015 Sep; 290(36):22184-92. PubMed ID: 26205822
[TBL] [Abstract][Full Text] [Related]
10. GPG-NH2 acts via the metabolite alphaHGA to target HIV-1 Env to the ER-associated protein degradation pathway.
Jejcic A; Höglund S; Vahlne A
Retrovirology; 2010 Mar; 7():20. PubMed ID: 20230608
[TBL] [Abstract][Full Text] [Related]
11. Transfer of endoplasmic reticulum and Golgi retention signals to human immunodeficiency virus type 1 gp160 inhibits intracellular transport and proteolytic processing of viral glycoprotein but does not influence the cellular site of virus particle budding.
Pfeiffer T; Zentgraf H; Freyaldenhoven B; Bosch V
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1745-53. PubMed ID: 9225051
[TBL] [Abstract][Full Text] [Related]
12. Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide.
Snapp EL; McCaul N; Quandte M; Cabartova Z; Bontjer I; Källgren C; Nilsson I; Land A; von Heijne G; Sanders RW; Braakman I
Elife; 2017 Jul; 6():. PubMed ID: 28753126
[TBL] [Abstract][Full Text] [Related]
13. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
Fenouillet E; Jones IM
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
[TBL] [Abstract][Full Text] [Related]
14. Cells transfected with a non-neutralizing antibody gene are resistant to HIV infection: targeting the endoplasmic reticulum and trans-Golgi network.
Zhou P; Goldstein S; Devadas K; Tewari D; Notkins AL
J Immunol; 1998 Feb; 160(3):1489-96. PubMed ID: 9570571
[TBL] [Abstract][Full Text] [Related]
15. Fusion of an intact secretory protein permits a misfolded protein to exit from the endoplasmic reticulum in yeast.
Suyama K; Hori M; Gomi K; Shintani T
Biosci Biotechnol Biochem; 2014; 78(1):49-59. PubMed ID: 25036483
[TBL] [Abstract][Full Text] [Related]
16. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.
Koga Y; Nakamura K; Sasaki M; Kimura G; Nomoto K
Virology; 1994 May; 201(1):137-41. PubMed ID: 8178478
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Natural Defense Against HIV With Therapeutic Potential.
Poveda E
AIDS Rev; 2015; 17(4):238. PubMed ID: 26690492
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
Fenouillet E; Miquelis R; Drillien R
Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
[TBL] [Abstract][Full Text] [Related]
19. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage.
Pancera M; Wyatt R
Virology; 2005 Feb; 332(1):145-56. PubMed ID: 15661147
[TBL] [Abstract][Full Text] [Related]
20. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
Tani Y; Tian H; Lane HC; Cohen DI
J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
